Enrichment of SNPs predisposing to immune-mediated diseases within HMRs
GWAS . | No. of associated SNPs . | HMR . | Cell-type–specific HMR* . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CD4 . | CD8 . | CD14 . | CD16 . | CD19 . | PBMC . | CD4 . | CD8 . | CD14 . | CD16 . | CD19 . | ||
Crohn's disease | 70 | 30† | 30† | 33† | 32† | 29† | 28† | 12 (1)† | 9 (2)† | 10† | 11† | 12 (1)† |
Primary biliary cirrhosis | 20 | 10† | 10† | 11† | 11† | 10† | 9 | 2† | 2† | 4† | 2 | 3 |
T1D | 64 | 25† | 24† | 23† | 24† | 24† | 22† | 6 (2)† | 2 | 6 (1) | 6 (1) | 5 |
Ulcerative colitis | 45 | 16 | 15 | 17 | 16 | 16 | 14 | 4 | 4 (1) | 3 | 5 (1) | 4 |
GWAS . | No. of associated SNPs . | HMR . | Cell-type–specific HMR* . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CD4 . | CD8 . | CD14 . | CD16 . | CD19 . | PBMC . | CD4 . | CD8 . | CD14 . | CD16 . | CD19 . | ||
Crohn's disease | 70 | 30† | 30† | 33† | 32† | 29† | 28† | 12 (1)† | 9 (2)† | 10† | 11† | 12 (1)† |
Primary biliary cirrhosis | 20 | 10† | 10† | 11† | 11† | 10† | 9 | 2† | 2† | 4† | 2 | 3 |
T1D | 64 | 25† | 24† | 23† | 24† | 24† | 22† | 6 (2)† | 2 | 6 (1) | 6 (1) | 5 |
Ulcerative colitis | 45 | 16 | 15 | 17 | 16 | 16 | 14 | 4 | 4 (1) | 3 | 5 (1) | 4 |